Related Experiment Video
Updated: Jan 11, 2026

09:16
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Published on: November 26, 2018
7.5K
Burnout and job satisfaction among hematologists: A cross-sectional study
Gamze Gürcan1, Başak Bostankolu Değirmenci2
1Department of Psychiatry, TOBB University of Economics and Technology, Faculty of Medicine, Ankara, Türkiye.
Medicine
|November 15, 2025
Summary
Burnout is common in hematologists, negatively impacting job satisfaction, especially emotional exhaustion. Voluntary specialty choice and experience may improve well-being, highlighting the need for support.
Area of Science:
- Medical Science
- Psychology
- Occupational Health
Background:
- Burnout and job satisfaction are critical issues for healthcare professionals.
- Hematology is a high-stress specialty with underexplored burnout and satisfaction levels.
Purpose of the Study:
- To evaluate burnout and job satisfaction in Turkish hematologists.
- To explore associations between burnout, job satisfaction, and sociodemographic factors.
Main Methods:
- Cross-sectional study of 139 hematologists in Turkey.
- Utilized sociodemographic questionnaire, Maslach Burnout Inventory, and Job Satisfaction Survey.
- Statistical analyses included Spearman correlations and group comparisons (P<.05).
Main Results:
- High emotional exhaustion (21.6%) and moderate levels (66.2%) were reported.
- Significant negative correlation between emotional exhaustion and job satisfaction (r=-0.404, P<.001).
- Voluntary specialty choice linked to lower burnout and higher job satisfaction; psychological distress associated with higher burnout.
Conclusions:
- Burnout is prevalent among hematologists and significantly impacts job satisfaction.
- Organizational support and individual coping strategies are crucial for improving hematologist well-being.
- Further research is needed to establish causality and develop targeted interventions.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Hematopoiesis
8.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.6K
Assessment of the Cardiovascular System I: Subjective Data
742
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
742
Bone Marrow Sampling and Transplants
846
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
846

